nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimecrolimus—CYP3A4—Temozolomide—brain cancer	0.186	0.486	CbGbCtD
Pimecrolimus—CYP3A4—Lomustine—brain cancer	0.158	0.414	CbGbCtD
Pimecrolimus—CYP3A4—Etoposide—brain cancer	0.0381	0.1	CbGbCtD
Pimecrolimus—Condition aggravated—Temozolomide—brain cancer	0.012	0.048	CcSEcCtD
Pimecrolimus—MTOR—blood vessel—brain cancer	0.0106	0.111	CbGeAlD
Pimecrolimus—Leukaemia—Hydroxyurea—brain cancer	0.0104	0.0416	CcSEcCtD
Pimecrolimus—MTOR—hindbrain—brain cancer	0.0101	0.106	CbGeAlD
Pimecrolimus—Skin atrophy—Hydroxyurea—brain cancer	0.00929	0.0371	CcSEcCtD
Pimecrolimus—Skin cancer—Hydroxyurea—brain cancer	0.00904	0.0362	CcSEcCtD
Pimecrolimus—Throat sore—Lomustine—brain cancer	0.00792	0.0317	CcSEcCtD
Pimecrolimus—Oropharyngeal discomfort—Lomustine—brain cancer	0.00785	0.0314	CcSEcCtD
Pimecrolimus—Oropharyngeal pain—Lomustine—brain cancer	0.00628	0.0251	CcSEcCtD
Pimecrolimus—Skin hyperpigmentation—Procarbazine—brain cancer	0.00609	0.0244	CcSEcCtD
Pimecrolimus—MTOR—brainstem—brain cancer	0.00579	0.0606	CbGeAlD
Pimecrolimus—MTOR—telencephalon—brain cancer	0.00514	0.0538	CbGeAlD
Pimecrolimus—Skin hyperpigmentation—Hydroxyurea—brain cancer	0.00471	0.0189	CcSEcCtD
Pimecrolimus—FKBP1A—telencephalon—brain cancer	0.00462	0.0484	CbGeAlD
Pimecrolimus—MTOR—gonad—brain cancer	0.00429	0.0449	CbGeAlD
Pimecrolimus—Neoplasm malignant—Procarbazine—brain cancer	0.00424	0.017	CcSEcCtD
Pimecrolimus—MTOR—pituitary gland—brain cancer	0.00418	0.0438	CbGeAlD
Pimecrolimus—FKBP1A—gonad—brain cancer	0.00386	0.0404	CbGeAlD
Pimecrolimus—Skin hyperpigmentation—Carmustine—brain cancer	0.00381	0.0152	CcSEcCtD
Pimecrolimus—FKBP1A—pituitary gland—brain cancer	0.00376	0.0394	CbGeAlD
Pimecrolimus—FKBP1A—medulla oblongata—brain cancer	0.00363	0.038	CbGeAlD
Pimecrolimus—MTOR—spinal cord—brain cancer	0.0036	0.0377	CbGeAlD
Pimecrolimus—FKBP1A—midbrain—brain cancer	0.00332	0.0347	CbGeAlD
Pimecrolimus—MTOR—endocrine gland—brain cancer	0.00324	0.0339	CbGeAlD
Pimecrolimus—FKBP1A—spinal cord—brain cancer	0.00324	0.0339	CbGeAlD
Pimecrolimus—MTOR—head—brain cancer	0.0032	0.0335	CbGeAlD
Pimecrolimus—MTOR—central nervous system—brain cancer	0.00292	0.0306	CbGeAlD
Pimecrolimus—FKBP1A—endocrine gland—brain cancer	0.00292	0.0305	CbGeAlD
Pimecrolimus—FKBP1A—head—brain cancer	0.00288	0.0301	CbGeAlD
Pimecrolimus—MTOR—cerebellum—brain cancer	0.00285	0.0299	CbGeAlD
Pimecrolimus—Otitis media—Temozolomide—brain cancer	0.00281	0.0113	CcSEcCtD
Pimecrolimus—Skin exfoliation—Hydroxyurea—brain cancer	0.00268	0.0107	CcSEcCtD
Pimecrolimus—FKBP1A—central nervous system—brain cancer	0.00263	0.0275	CbGeAlD
Pimecrolimus—FKBP1A—cerebellum—brain cancer	0.00257	0.0269	CbGeAlD
Pimecrolimus—Viral infection—Temozolomide—brain cancer	0.00243	0.0097	CcSEcCtD
Pimecrolimus—Herpes simplex—Temozolomide—brain cancer	0.00238	0.00951	CcSEcCtD
Pimecrolimus—MTOR—brain—brain cancer	0.00232	0.0243	CbGeAlD
Pimecrolimus—Infection—Carboplatin—brain cancer	0.00231	0.00925	CcSEcCtD
Pimecrolimus—Skin exfoliation—Carmustine—brain cancer	0.00216	0.00865	CcSEcCtD
Pimecrolimus—Influenza like illness—Temozolomide—brain cancer	0.00213	0.00851	CcSEcCtD
Pimecrolimus—Skin exfoliation—Temozolomide—brain cancer	0.00209	0.00836	CcSEcCtD
Pimecrolimus—FKBP1A—brain—brain cancer	0.00209	0.0218	CbGeAlD
Pimecrolimus—Photosensitivity reaction—Procarbazine—brain cancer	0.00207	0.0083	CcSEcCtD
Pimecrolimus—Pneumonia—Procarbazine—brain cancer	0.00204	0.00815	CcSEcCtD
Pimecrolimus—Infection—Lomustine—brain cancer	0.00202	0.00809	CcSEcCtD
Pimecrolimus—Pain—Carboplatin—brain cancer	0.00199	0.00796	CcSEcCtD
Pimecrolimus—Face oedema—Hydroxyurea—brain cancer	0.00197	0.00786	CcSEcCtD
Pimecrolimus—Skin discolouration—Etoposide—brain cancer	0.00194	0.00776	CcSEcCtD
Pimecrolimus—Epistaxis—Procarbazine—brain cancer	0.00191	0.00764	CcSEcCtD
Pimecrolimus—Swelling—Carmustine—brain cancer	0.00187	0.00746	CcSEcCtD
Pimecrolimus—Ear pain—Temozolomide—brain cancer	0.00186	0.00745	CcSEcCtD
Pimecrolimus—Body temperature increased—Carboplatin—brain cancer	0.00184	0.00736	CcSEcCtD
Pimecrolimus—Breast disorder—Hydroxyurea—brain cancer	0.00184	0.00736	CcSEcCtD
Pimecrolimus—Gastroenteritis—Temozolomide—brain cancer	0.00179	0.00717	CcSEcCtD
Pimecrolimus—Nasal congestion—Temozolomide—brain cancer	0.00175	0.00698	CcSEcCtD
Pimecrolimus—Flushing—Procarbazine—brain cancer	0.00169	0.00675	CcSEcCtD
Pimecrolimus—Dermatitis exfoliative—Temozolomide—brain cancer	0.00169	0.00674	CcSEcCtD
Pimecrolimus—Skin exfoliation—Etoposide—brain cancer	0.00167	0.00669	CcSEcCtD
Pimecrolimus—Body temperature increased—Lomustine—brain cancer	0.00161	0.00644	CcSEcCtD
Pimecrolimus—Face oedema—Carmustine—brain cancer	0.00159	0.00635	CcSEcCtD
Pimecrolimus—Infestation NOS—Hydroxyurea—brain cancer	0.00157	0.00627	CcSEcCtD
Pimecrolimus—Infestation—Hydroxyurea—brain cancer	0.00157	0.00627	CcSEcCtD
Pimecrolimus—Face oedema—Temozolomide—brain cancer	0.00154	0.00614	CcSEcCtD
Pimecrolimus—Swelling—Etoposide—brain cancer	0.00144	0.00577	CcSEcCtD
Pimecrolimus—Breast disorder—Temozolomide—brain cancer	0.00144	0.00575	CcSEcCtD
Pimecrolimus—Cough—Procarbazine—brain cancer	0.00138	0.00553	CcSEcCtD
Pimecrolimus—Arthralgia—Procarbazine—brain cancer	0.00135	0.00539	CcSEcCtD
Pimecrolimus—Bronchitis—Temozolomide—brain cancer	0.00132	0.00529	CcSEcCtD
Pimecrolimus—Vomiting—Lomustine—brain cancer	0.00129	0.00518	CcSEcCtD
Pimecrolimus—Oedema—Procarbazine—brain cancer	0.00129	0.00517	CcSEcCtD
Pimecrolimus—Infection—Procarbazine—brain cancer	0.00128	0.00514	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Temozolomide—brain cancer	0.00128	0.00511	CcSEcCtD
Pimecrolimus—Pneumonia—Carmustine—brain cancer	0.00128	0.0051	CcSEcCtD
Pimecrolimus—Photosensitivity reaction—Temozolomide—brain cancer	0.00125	0.00502	CcSEcCtD
Pimecrolimus—Pneumonia—Temozolomide—brain cancer	0.00123	0.00493	CcSEcCtD
Pimecrolimus—Erythema—Hydroxyurea—brain cancer	0.00123	0.0049	CcSEcCtD
Pimecrolimus—Infestation NOS—Temozolomide—brain cancer	0.00123	0.0049	CcSEcCtD
Pimecrolimus—Infestation—Temozolomide—brain cancer	0.00123	0.0049	CcSEcCtD
Pimecrolimus—Nausea—Lomustine—brain cancer	0.00121	0.00484	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00118	0.00471	CcSEcCtD
Pimecrolimus—Paraesthesia—Procarbazine—brain cancer	0.00116	0.00464	CcSEcCtD
Pimecrolimus—Sinusitis—Temozolomide—brain cancer	0.00115	0.0046	CcSEcCtD
Pimecrolimus—Pain—Procarbazine—brain cancer	0.00111	0.00442	CcSEcCtD
Pimecrolimus—Constipation—Procarbazine—brain cancer	0.00111	0.00442	CcSEcCtD
Pimecrolimus—Pharyngitis—Temozolomide—brain cancer	0.00109	0.00437	CcSEcCtD
Pimecrolimus—Eye disorder—Carmustine—brain cancer	0.00106	0.00425	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Procarbazine—brain cancer	0.00106	0.00423	CcSEcCtD
Pimecrolimus—Flushing—Carmustine—brain cancer	0.00106	0.00422	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00104	0.00414	CcSEcCtD
Pimecrolimus—Eye disorder—Temozolomide—brain cancer	0.00103	0.00411	CcSEcCtD
Pimecrolimus—Urticaria—Procarbazine—brain cancer	0.00103	0.00411	CcSEcCtD
Pimecrolimus—Body temperature increased—Procarbazine—brain cancer	0.00102	0.00409	CcSEcCtD
Pimecrolimus—Abdominal pain—Procarbazine—brain cancer	0.00102	0.00409	CcSEcCtD
Pimecrolimus—Flushing—Temozolomide—brain cancer	0.00102	0.00408	CcSEcCtD
Pimecrolimus—Oedema—Hydroxyurea—brain cancer	0.001	0.004	CcSEcCtD
Pimecrolimus—Infection—Hydroxyurea—brain cancer	0.000994	0.00397	CcSEcCtD
Pimecrolimus—Immune system disorder—Temozolomide—brain cancer	0.000994	0.00397	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Temozolomide—brain cancer	0.000991	0.00396	CcSEcCtD
Pimecrolimus—Erythema—Carmustine—brain cancer	0.000991	0.00396	CcSEcCtD
Pimecrolimus—Malnutrition—Carmustine—brain cancer	0.000991	0.00396	CcSEcCtD
Pimecrolimus—Pneumonia—Etoposide—brain cancer	0.000986	0.00394	CcSEcCtD
Pimecrolimus—Nervous system disorder—Hydroxyurea—brain cancer	0.000981	0.00392	CcSEcCtD
Pimecrolimus—Infestation NOS—Etoposide—brain cancer	0.000981	0.00392	CcSEcCtD
Pimecrolimus—Infestation—Etoposide—brain cancer	0.000981	0.00392	CcSEcCtD
Pimecrolimus—Skin disorder—Hydroxyurea—brain cancer	0.000972	0.00389	CcSEcCtD
Pimecrolimus—Back pain—Carmustine—brain cancer	0.000959	0.00383	CcSEcCtD
Pimecrolimus—Malnutrition—Temozolomide—brain cancer	0.000958	0.00383	CcSEcCtD
Pimecrolimus—Erythema—Temozolomide—brain cancer	0.000958	0.00383	CcSEcCtD
Pimecrolimus—CYP3A4—endocrine gland—brain cancer	0.000953	0.00997	CbGeAlD
Pimecrolimus—Hypersensitivity—Procarbazine—brain cancer	0.000952	0.00381	CcSEcCtD
Pimecrolimus—Back pain—Temozolomide—brain cancer	0.000926	0.0037	CcSEcCtD
Pimecrolimus—Pruritus—Procarbazine—brain cancer	0.000915	0.00366	CcSEcCtD
Pimecrolimus—Dyspnoea—Hydroxyurea—brain cancer	0.000892	0.00357	CcSEcCtD
Pimecrolimus—Diarrhoea—Procarbazine—brain cancer	0.000884	0.00354	CcSEcCtD
Pimecrolimus—Angioedema—Temozolomide—brain cancer	0.000875	0.0035	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000864	0.00345	CcSEcCtD
Pimecrolimus—CYP3A4—central nervous system—brain cancer	0.000858	0.00898	CbGeAlD
Pimecrolimus—Pain—Hydroxyurea—brain cancer	0.000855	0.00342	CcSEcCtD
Pimecrolimus—Constipation—Hydroxyurea—brain cancer	0.000855	0.00342	CcSEcCtD
Pimecrolimus—Cough—Temozolomide—brain cancer	0.000836	0.00334	CcSEcCtD
Pimecrolimus—Eye disorder—Etoposide—brain cancer	0.000823	0.00329	CcSEcCtD
Pimecrolimus—Vomiting—Procarbazine—brain cancer	0.000822	0.00329	CcSEcCtD
Pimecrolimus—Flushing—Etoposide—brain cancer	0.000817	0.00327	CcSEcCtD
Pimecrolimus—Arthralgia—Temozolomide—brain cancer	0.000815	0.00326	CcSEcCtD
Pimecrolimus—Rash—Procarbazine—brain cancer	0.000815	0.00326	CcSEcCtD
Pimecrolimus—Dermatitis—Procarbazine—brain cancer	0.000814	0.00326	CcSEcCtD
Pimecrolimus—Headache—Procarbazine—brain cancer	0.00081	0.00324	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00081	0.00324	CcSEcCtD
Pimecrolimus—Oedema—Carmustine—brain cancer	0.000809	0.00323	CcSEcCtD
Pimecrolimus—Infection—Carmustine—brain cancer	0.000803	0.00321	CcSEcCtD
Pimecrolimus—Immune system disorder—Etoposide—brain cancer	0.000795	0.00318	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Etoposide—brain cancer	0.000793	0.00317	CcSEcCtD
Pimecrolimus—Body temperature increased—Hydroxyurea—brain cancer	0.000791	0.00316	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Temozolomide—brain cancer	0.000782	0.00313	CcSEcCtD
Pimecrolimus—Oedema—Temozolomide—brain cancer	0.000782	0.00313	CcSEcCtD
Pimecrolimus—Infection—Temozolomide—brain cancer	0.000776	0.0031	CcSEcCtD
Pimecrolimus—Nausea—Procarbazine—brain cancer	0.000768	0.00307	CcSEcCtD
Pimecrolimus—Nervous system disorder—Temozolomide—brain cancer	0.000766	0.00306	CcSEcCtD
Pimecrolimus—Skin disorder—Temozolomide—brain cancer	0.000759	0.00304	CcSEcCtD
Pimecrolimus—Back pain—Etoposide—brain cancer	0.000741	0.00296	CcSEcCtD
Pimecrolimus—Hypersensitivity—Hydroxyurea—brain cancer	0.000737	0.00295	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Carmustine—brain cancer	0.000737	0.00295	CcSEcCtD
Pimecrolimus—Paraesthesia—Carmustine—brain cancer	0.000726	0.0029	CcSEcCtD
Pimecrolimus—Dyspnoea—Carmustine—brain cancer	0.000721	0.00288	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000712	0.00285	CcSEcCtD
Pimecrolimus—Paraesthesia—Temozolomide—brain cancer	0.000702	0.00281	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Carmustine—brain cancer	0.000698	0.00279	CcSEcCtD
Pimecrolimus—Dyspnoea—Temozolomide—brain cancer	0.000697	0.00279	CcSEcCtD
Pimecrolimus—Constipation—Carmustine—brain cancer	0.000692	0.00277	CcSEcCtD
Pimecrolimus—Pain—Carmustine—brain cancer	0.000692	0.00277	CcSEcCtD
Pimecrolimus—Diarrhoea—Hydroxyurea—brain cancer	0.000684	0.00274	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Temozolomide—brain cancer	0.000675	0.0027	CcSEcCtD
Pimecrolimus—Cough—Etoposide—brain cancer	0.000669	0.00267	CcSEcCtD
Pimecrolimus—Pain—Temozolomide—brain cancer	0.000668	0.00267	CcSEcCtD
Pimecrolimus—Constipation—Temozolomide—brain cancer	0.000668	0.00267	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Carmustine—brain cancer	0.000661	0.00264	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000648	0.00259	CcSEcCtD
Pimecrolimus—Abdominal pain—Carmustine—brain cancer	0.000639	0.00256	CcSEcCtD
Pimecrolimus—Body temperature increased—Carmustine—brain cancer	0.000639	0.00256	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Temozolomide—brain cancer	0.000639	0.00256	CcSEcCtD
Pimecrolimus—Vomiting—Hydroxyurea—brain cancer	0.000636	0.00254	CcSEcCtD
Pimecrolimus—Rash—Hydroxyurea—brain cancer	0.000631	0.00252	CcSEcCtD
Pimecrolimus—Dermatitis—Hydroxyurea—brain cancer	0.00063	0.00252	CcSEcCtD
Pimecrolimus—Headache—Hydroxyurea—brain cancer	0.000627	0.00251	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Etoposide—brain cancer	0.000625	0.0025	CcSEcCtD
Pimecrolimus—Infection—Etoposide—brain cancer	0.000621	0.00248	CcSEcCtD
Pimecrolimus—Urticaria—Temozolomide—brain cancer	0.000621	0.00248	CcSEcCtD
Pimecrolimus—Abdominal pain—Temozolomide—brain cancer	0.000618	0.00247	CcSEcCtD
Pimecrolimus—Body temperature increased—Temozolomide—brain cancer	0.000618	0.00247	CcSEcCtD
Pimecrolimus—Skin disorder—Etoposide—brain cancer	0.000607	0.00243	CcSEcCtD
Pimecrolimus—Hypersensitivity—Carmustine—brain cancer	0.000596	0.00238	CcSEcCtD
Pimecrolimus—Nausea—Hydroxyurea—brain cancer	0.000594	0.00238	CcSEcCtD
Pimecrolimus—Hypersensitivity—Temozolomide—brain cancer	0.000576	0.0023	CcSEcCtD
Pimecrolimus—Paraesthesia—Etoposide—brain cancer	0.000562	0.00225	CcSEcCtD
Pimecrolimus—Dyspnoea—Etoposide—brain cancer	0.000558	0.00223	CcSEcCtD
Pimecrolimus—Diarrhoea—Carmustine—brain cancer	0.000553	0.00221	CcSEcCtD
Pimecrolimus—Pruritus—Temozolomide—brain cancer	0.000553	0.00221	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Etoposide—brain cancer	0.00054	0.00216	CcSEcCtD
Pimecrolimus—Constipation—Etoposide—brain cancer	0.000535	0.00214	CcSEcCtD
Pimecrolimus—Pain—Etoposide—brain cancer	0.000535	0.00214	CcSEcCtD
Pimecrolimus—Diarrhoea—Temozolomide—brain cancer	0.000535	0.00214	CcSEcCtD
Pimecrolimus—Vomiting—Carmustine—brain cancer	0.000514	0.00206	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Etoposide—brain cancer	0.000511	0.00204	CcSEcCtD
Pimecrolimus—Rash—Carmustine—brain cancer	0.00051	0.00204	CcSEcCtD
Pimecrolimus—Dermatitis—Carmustine—brain cancer	0.000509	0.00204	CcSEcCtD
Pimecrolimus—Headache—Carmustine—brain cancer	0.000507	0.00203	CcSEcCtD
Pimecrolimus—Vomiting—Temozolomide—brain cancer	0.000497	0.00199	CcSEcCtD
Pimecrolimus—Urticaria—Etoposide—brain cancer	0.000497	0.00199	CcSEcCtD
Pimecrolimus—Abdominal pain—Etoposide—brain cancer	0.000494	0.00198	CcSEcCtD
Pimecrolimus—Body temperature increased—Etoposide—brain cancer	0.000494	0.00198	CcSEcCtD
Pimecrolimus—Rash—Temozolomide—brain cancer	0.000493	0.00197	CcSEcCtD
Pimecrolimus—Dermatitis—Temozolomide—brain cancer	0.000492	0.00197	CcSEcCtD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—CDKN2A—brain cancer	0.000491	0.0018	CbGpPWpGaD
Pimecrolimus—Headache—Temozolomide—brain cancer	0.00049	0.00196	CcSEcCtD
Pimecrolimus—MTOR—Insulin Signaling—IRS2—brain cancer	0.000489	0.00179	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—SPP1—brain cancer	0.000488	0.00179	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signal transduction—IRS2—brain cancer	0.000487	0.00178	CbGpPWpGaD
Pimecrolimus—MTOR—PI3K/AKT activation—ERBB2—brain cancer	0.000485	0.00178	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR—IRS2—brain cancer	0.000484	0.00177	CbGpPWpGaD
Pimecrolimus—MTOR—TSH signaling pathway—MYC—brain cancer	0.000483	0.00177	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB2—IRS2—brain cancer	0.000482	0.00177	CbGpPWpGaD
Pimecrolimus—MTOR—GAB1 signalosome—ERBB2—brain cancer	0.000481	0.00176	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000481	0.00176	CbGpPWpGaD
Pimecrolimus—Nausea—Carmustine—brain cancer	0.00048	0.00192	CcSEcCtD
Pimecrolimus—MTOR—DAP12 signaling—IRS2—brain cancer	0.000479	0.00176	CbGpPWpGaD
Pimecrolimus—MTOR—B Cell Activation—PDGFRA—brain cancer	0.000475	0.00174	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—IRS2—brain cancer	0.000473	0.00173	CbGpPWpGaD
Pimecrolimus—MTOR—Regulation of Telomerase—MYC—brain cancer	0.000471	0.00173	CbGpPWpGaD
Pimecrolimus—MTOR—BDNF signaling pathway—APC—brain cancer	0.00047	0.00172	CbGpPWpGaD
Pimecrolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—ERBB2—brain cancer	0.00047	0.00172	CbGpPWpGaD
Pimecrolimus—MTOR—Leptin signaling pathway—STAT3—brain cancer	0.000469	0.00172	CbGpPWpGaD
Pimecrolimus—MTOR—ErbB Signaling Pathway—TP53—brain cancer	0.000465	0.0017	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—DTX2—brain cancer	0.000465	0.0017	CbGpPWpGaD
Pimecrolimus—Nausea—Temozolomide—brain cancer	0.000464	0.00186	CcSEcCtD
Pimecrolimus—MTOR—Regulation of Telomerase—EGFR—brain cancer	0.000461	0.00169	CbGpPWpGaD
Pimecrolimus—Hypersensitivity—Etoposide—brain cancer	0.000461	0.00184	CcSEcCtD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000457	0.00168	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—PDGFRA—brain cancer	0.000455	0.00167	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000453	0.00166	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IRS2—brain cancer	0.000451	0.00165	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 interactions—IRS2—brain cancer	0.000451	0.00165	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR in disease—IRS2—brain cancer	0.000451	0.00165	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR—IRS2—brain cancer	0.000447	0.00164	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR in Cancer—IRS2—brain cancer	0.000443	0.00162	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—TP53—brain cancer	0.000443	0.00162	CbGpPWpGaD
Pimecrolimus—Pruritus—Etoposide—brain cancer	0.000442	0.00177	CcSEcCtD
Pimecrolimus—MTOR—Signaling by PDGF—IRS2—brain cancer	0.000441	0.00162	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—PTCH2—brain cancer	0.000439	0.00161	CbGpPWpGaD
Pimecrolimus—MTOR—Insulin Signaling—PIK3CG—brain cancer	0.000432	0.00158	CbGpPWpGaD
Pimecrolimus—MTOR—CXCR4-mediated signaling events—STAT3—brain cancer	0.000428	0.00157	CbGpPWpGaD
Pimecrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—STAT3—brain cancer	0.000428	0.00157	CbGpPWpGaD
Pimecrolimus—Diarrhoea—Etoposide—brain cancer	0.000428	0.00171	CcSEcCtD
Pimecrolimus—MTOR—Signaling by NGF—VAV1—brain cancer	0.000427	0.00157	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—HES5—brain cancer	0.000425	0.00156	CbGpPWpGaD
Pimecrolimus—MTOR—B Cell Activation—IRS2—brain cancer	0.000417	0.00153	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—STRADA—brain cancer	0.000412	0.00151	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—IDH1—brain cancer	0.000408	0.0015	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000408	0.00149	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—SIRT1—brain cancer	0.000406	0.00149	CbGpPWpGaD
Pimecrolimus—MTOR—VEGFA-VEGFR2 Pathway—CTNNB1—brain cancer	0.000405	0.00148	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000402	0.00147	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—CCNE1—brain cancer	0.000401	0.00147	CbGpPWpGaD
Pimecrolimus—MTOR—Oncostatin M Signaling Pathway—TP53—brain cancer	0.000401	0.00147	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IRS2—brain cancer	0.000399	0.00146	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000399	0.00146	CbGpPWpGaD
Pimecrolimus—Vomiting—Etoposide—brain cancer	0.000398	0.00159	CcSEcCtD
Pimecrolimus—Rash—Etoposide—brain cancer	0.000394	0.00158	CcSEcCtD
Pimecrolimus—Dermatitis—Etoposide—brain cancer	0.000394	0.00158	CcSEcCtD
Pimecrolimus—Headache—Etoposide—brain cancer	0.000392	0.00157	CcSEcCtD
Pimecrolimus—MTOR—Cellular responses to stress—SOD2—brain cancer	0.000391	0.00143	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—HEY1—brain cancer	0.000387	0.00142	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—OR4C12—brain cancer	0.000383	0.0014	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—OR14C36—brain cancer	0.000383	0.0014	CbGpPWpGaD
Pimecrolimus—MTOR—AMPK Signaling—TP53—brain cancer	0.000382	0.0014	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by VEGF—CTNNB1—brain cancer	0.000382	0.0014	CbGpPWpGaD
Pimecrolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—EGFR—brain cancer	0.000382	0.0014	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—DLL1—brain cancer	0.000379	0.00139	CbGpPWpGaD
Pimecrolimus—Nausea—Etoposide—brain cancer	0.000371	0.00149	CcSEcCtD
Pimecrolimus—MTOR—Signaling by SCF-KIT—ERBB2—brain cancer	0.000371	0.00136	CbGpPWpGaD
Pimecrolimus—MTOR—BDNF signaling pathway—RELA—brain cancer	0.000367	0.00135	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000367	0.00134	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000359	0.00131	CbGpPWpGaD
Pimecrolimus—MTOR—ErbB1 downstream signaling—STAT3—brain cancer	0.000358	0.00131	CbGpPWpGaD
Pimecrolimus—MTOR—VEGFA-VEGFR2 Pathway—VEGFA—brain cancer	0.000356	0.00131	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling of activated FGFR—ERBB2—brain cancer	0.000355	0.0013	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—PDGFRA—brain cancer	0.00035	0.00128	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB4—ERBB2—brain cancer	0.000349	0.00128	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—ABR—brain cancer	0.000344	0.00126	CbGpPWpGaD
Pimecrolimus—MTOR—PI-3K cascade—EGFR—brain cancer	0.000344	0.00126	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—HES5—brain cancer	0.000341	0.00125	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by VEGF—VEGFA—brain cancer	0.000336	0.00123	CbGpPWpGaD
Pimecrolimus—MTOR—PI3K/AKT activation—EGFR—brain cancer	0.000336	0.00123	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signal transduction—ERBB2—brain cancer	0.000334	0.00122	CbGpPWpGaD
Pimecrolimus—MTOR—GAB1 signalosome—EGFR—brain cancer	0.000333	0.00122	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—GLI2—brain cancer	0.000332	0.00122	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR—ERBB2—brain cancer	0.000332	0.00122	CbGpPWpGaD
Pimecrolimus—MTOR—EGF/EGFR Signaling Pathway—ERBB2—brain cancer	0.000332	0.00122	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB2—ERBB2—brain cancer	0.00033	0.00121	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 signaling—ERBB2—brain cancer	0.000329	0.0012	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—RELA—brain cancer	0.000326	0.00119	CbGpPWpGaD
Pimecrolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—brain cancer	0.000326	0.00119	CbGpPWpGaD
Pimecrolimus—MTOR—ErbB1 downstream signaling—EGFR—brain cancer	0.000326	0.00119	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—DTX2—brain cancer	0.000325	0.00119	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—brain cancer	0.000324	0.00119	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—ENO2—brain cancer	0.000323	0.00118	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—SHH—brain cancer	0.000323	0.00118	CbGpPWpGaD
Pimecrolimus—MTOR—BDNF signaling pathway—CTNNB1—brain cancer	0.000319	0.00117	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—GLI1—brain cancer	0.000312	0.00114	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—RELA—brain cancer	0.000311	0.00114	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.00031	0.00114	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—ERBB2—brain cancer	0.000309	0.00113	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR in disease—ERBB2—brain cancer	0.000309	0.00113	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 interactions—ERBB2—brain cancer	0.000309	0.00113	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—CDK4—brain cancer	0.000307	0.00113	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.000307	0.00113	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—IRS2—brain cancer	0.000307	0.00113	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—SKP2—brain cancer	0.000307	0.00113	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR—ERBB2—brain cancer	0.000307	0.00112	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR in Cancer—ERBB2—brain cancer	0.000304	0.00111	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—ERBB2—brain cancer	0.000302	0.00111	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.000301	0.0011	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—SUFU—brain cancer	0.000296	0.00109	CbGpPWpGaD
Pimecrolimus—MTOR—B Cell Activation—RELA—brain cancer	0.000288	0.00106	CbGpPWpGaD
Pimecrolimus—MTOR—B Cell Activation—ERBB2—brain cancer	0.000286	0.00105	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—GFAP—brain cancer	0.000286	0.00105	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by SCF-KIT—STAT3—brain cancer	0.000283	0.00104	CbGpPWpGaD
Pimecrolimus—MTOR—BDNF signaling pathway—STAT3—brain cancer	0.000278	0.00102	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—ERBB2—brain cancer	0.000274	0.001	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—TP53—brain cancer	0.000273	0.001	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—HEY1—brain cancer	0.000271	0.000993	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.000271	0.000991	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—DLL1—brain cancer	0.000266	0.000973	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by SCF-KIT—EGFR—brain cancer	0.000257	0.000942	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signal transduction—STAT3—brain cancer	0.000254	0.000932	CbGpPWpGaD
Pimecrolimus—MTOR—EGF/EGFR Signaling Pathway—STAT3—brain cancer	0.000253	0.000928	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—MYC—brain cancer	0.000249	0.000912	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PTCH2—brain cancer	0.000247	0.000904	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling of activated FGFR—EGFR—brain cancer	0.000246	0.000902	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—VAV1—brain cancer	0.000244	0.000893	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—EGFR—brain cancer	0.000243	0.000892	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB4—EGFR—brain cancer	0.000242	0.000887	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—HES5—brain cancer	0.000239	0.000875	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR in disease—STAT3—brain cancer	0.000236	0.000864	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—CDKN2A—brain cancer	0.000235	0.000861	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—VAV1—brain cancer	0.000234	0.000858	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—VAV1—brain cancer	0.000233	0.000854	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—STRADA—brain cancer	0.000232	0.00085	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signal transduction—EGFR—brain cancer	0.000231	0.000847	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—STAT3—brain cancer	0.000231	0.000845	CbGpPWpGaD
Pimecrolimus—MTOR—EGF/EGFR Signaling Pathway—EGFR—brain cancer	0.00023	0.000843	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR—EGFR—brain cancer	0.00023	0.000843	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—IDH1—brain cancer	0.00023	0.000841	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB2—EGFR—brain cancer	0.000229	0.000839	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 signaling—EGFR—brain cancer	0.000228	0.000835	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—RELA—brain cancer	0.000226	0.000828	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—SHH—brain cancer	0.000226	0.000828	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—EGFR—brain cancer	0.000225	0.000823	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—TRPC6—brain cancer	0.000218	0.000798	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—HEY1—brain cancer	0.000218	0.000797	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 interactions—EGFR—brain cancer	0.000214	0.000786	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR in disease—EGFR—brain cancer	0.000214	0.000786	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—EGFR—brain cancer	0.000214	0.000786	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—SMO—brain cancer	0.000214	0.000785	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—PTCH1—brain cancer	0.000214	0.000785	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—DLL1—brain cancer	0.000213	0.000782	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR—EGFR—brain cancer	0.000212	0.000778	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—RELA—brain cancer	0.000212	0.000777	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—ERBB2—brain cancer	0.000211	0.000772	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR in Cancer—EGFR—brain cancer	0.000211	0.000772	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—EGFR—brain cancer	0.00021	0.000768	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—STAT3—brain cancer	0.000209	0.000765	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—TP53—brain cancer	0.000204	0.000749	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—HES1—brain cancer	0.0002	0.000734	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—PDGFRA—brain cancer	0.0002	0.000731	CbGpPWpGaD
Pimecrolimus—MTOR—B Cell Activation—EGFR—brain cancer	0.000198	0.000727	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—ABR—brain cancer	0.000194	0.000709	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—PDGFRA—brain cancer	0.000192	0.000702	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—PDGFRA—brain cancer	0.000191	0.000699	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—EGFR—brain cancer	0.00019	0.000696	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—GLI2—brain cancer	0.000187	0.000685	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—SKP2—brain cancer	0.000186	0.000683	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—SHH—brain cancer	0.000181	0.000665	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—ENO2—brain cancer	0.000181	0.000665	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—GLI1—brain cancer	0.000176	0.000644	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—IRS2—brain cancer	0.000175	0.000642	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—VEGFA—brain cancer	0.000173	0.000634	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—STAT3—brain cancer	0.000171	0.000628	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—NOTCH2—brain cancer	0.000171	0.000627	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—IRS2—brain cancer	0.000168	0.000617	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—IRS2—brain cancer	0.000168	0.000614	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—SUFU—brain cancer	0.000167	0.00061	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—VAV1—brain cancer	0.000163	0.000598	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—GFAP—brain cancer	0.000161	0.000589	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—STAT3—brain cancer	0.000161	0.000589	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—HEY1—brain cancer	0.000152	0.000558	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—DLL1—brain cancer	0.000149	0.000547	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—APC—brain cancer	0.000148	0.000542	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—EGFR—brain cancer	0.000146	0.000535	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—VAV1—brain cancer	0.000142	0.00052	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—HES1—brain cancer	0.00014	0.000514	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—PDGFRA—brain cancer	0.000134	0.00049	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—VAV1—brain cancer	0.000131	0.00048	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—TP53—brain cancer	0.000131	0.000479	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—SPP1—brain cancer	0.00013	0.000475	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—SHH—brain cancer	0.000127	0.000466	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TRPC6—brain cancer	0.000123	0.000449	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—RELA—brain cancer	0.000121	0.000443	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—SMO—brain cancer	0.00012	0.000441	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PTCH1—brain cancer	0.00012	0.000441	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—ERBB2—brain cancer	0.00012	0.00044	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IRS2—brain cancer	0.000117	0.00043	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—PDGFRA—brain cancer	0.000116	0.000426	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—RELA—brain cancer	0.000116	0.000425	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—ERBB2—brain cancer	0.000115	0.000423	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—ERBB2—brain cancer	0.000115	0.000421	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—HES1—brain cancer	0.000113	0.000413	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—PDGFRA—brain cancer	0.000107	0.000393	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CTNNB1—brain cancer	0.000105	0.000385	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—APC—brain cancer	0.000104	0.00038	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—PIK3CG—brain cancer	0.000104	0.00038	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IRS2—brain cancer	0.000102	0.000374	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—CTNNB1—brain cancer	0.000101	0.000368	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NOTCH2—brain cancer	9.63e-05	0.000353	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—IRS2—brain cancer	9.42e-05	0.000345	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—VAV1—brain cancer	9.18e-05	0.000336	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—STAT3—brain cancer	8.76e-05	0.000321	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—EGFR—brain cancer	8.33e-05	0.000305	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—APC—brain cancer	8.32e-05	0.000305	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—MYC—brain cancer	8.14e-05	0.000298	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—RELA—brain cancer	8.1e-05	0.000297	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—ERBB2—brain cancer	8.05e-05	0.000295	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—EGFR—brain cancer	8e-05	0.000293	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—EGFR—brain cancer	7.97e-05	0.000292	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—HES1—brain cancer	7.89e-05	0.000289	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PDGFRA—brain cancer	7.52e-05	0.000275	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—SPP1—brain cancer	7.3e-05	0.000267	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IL2—brain cancer	7.29e-05	0.000267	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CCND1—brain cancer	7.11e-05	0.00026	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—RELA—brain cancer	7.04e-05	0.000258	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CTNNB1—brain cancer	7.04e-05	0.000258	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—ERBB2—brain cancer	7e-05	0.000256	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CYP2C9—brain cancer	6.97e-05	0.000255	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IRS2—brain cancer	6.6e-05	0.000242	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—ERBB2—brain cancer	6.46e-05	0.000237	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL2—brain cancer	6.34e-05	0.000232	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—VEGFA—brain cancer	6.2e-05	0.000227	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—STAT3—brain cancer	6.14e-05	0.000225	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CTNNB1—brain cancer	6.12e-05	0.000224	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—BSG—brain cancer	5.93e-05	0.000217	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—APC—brain cancer	5.83e-05	0.000214	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PIK3CG—brain cancer	5.83e-05	0.000214	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—MYC—brain cancer	5.7e-05	0.000209	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CTNNB1—brain cancer	5.65e-05	0.000207	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—EGFR—brain cancer	5.58e-05	0.000204	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—STAT3—brain cancer	5.34e-05	0.000196	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—IDH1—brain cancer	5.1e-05	0.000187	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—STAT3—brain cancer	4.93e-05	0.000181	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—EGFR—brain cancer	4.85e-05	0.000178	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—TP53—brain cancer	4.68e-05	0.000172	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—MYC—brain cancer	4.58e-05	0.000168	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—RELA—brain cancer	4.55e-05	0.000167	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—ERBB2—brain cancer	4.53e-05	0.000166	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—EGFR—brain cancer	4.48e-05	0.000164	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IL2—brain cancer	4.1e-05	0.00015	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ENO2—brain cancer	4.03e-05	0.000148	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CCND1—brain cancer	4e-05	0.000146	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CTNNB1—brain cancer	3.96e-05	0.000145	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—VEGFA—brain cancer	3.49e-05	0.000128	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—STAT3—brain cancer	3.45e-05	0.000126	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—MYC—brain cancer	3.21e-05	0.000118	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—EGFR—brain cancer	3.14e-05	0.000115	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TP53—brain cancer	2.63e-05	9.65e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PIK3CG—brain cancer	1.85e-05	6.77e-05	CbGpPWpGaD
